Usefulness of intravenous adenosine in idiopathic pulmonary arterial hypertension as a screening agent for identifying long-term responders to calcium channel blockers

American Journal of Cardiology

Volumn 109, Issue 12, 2012, Pages 1801-1806

  Zuo, Xiang Rong ^a,b   Zhang, Rui ^b   Jiang, Xin ^b   Li, Xin Li ^a   Zong, Feng ^a   Xie, Wei Ping ^a   Wang, Hong ^a   Jing, Zhi Cheng ^b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; BOSENTAN; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM;

ABDOMINAL PAIN; ADULT; ANXIETY; ARTERIAL PRESSURE; ARTICLE; BRONCHOSPASM; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG DOSE INCREASE; DRUG MEGADOSE; DRUG TOLERABILITY; FEMALE; FLUSHING; FOLLOW UP; HEADACHE; HEART PALPITATION; HEART RIGHT VENTRICLE FAILURE; HEMODYNAMICS; HUMAN; HYPOTENSION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; POST TREATMENT SURVIVAL; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SIDE EFFECT; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; VASODILATATION;

ADENOSINE; ADULT; CALCIUM CHANNEL BLOCKERS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FUNCTION TESTS; HEMODYNAMICS; HUMANS; HYPERTENSION, PULMONARY; MALE; MASS SCREENING; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; VASODILATOR AGENTS; YOUNG ADULT;

EID: 84862813227     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2012.02.026     Document Type: Article

References (20)

1. S. Rich, E. Kaufmann High dose titration of calcium channel blocking agents for primary pulmonary hypertension: guidelines for short-term drug testing J Am Coll Cardiol 18 1991 1323 1327
2. S. Rich, E. Kaufmann, P.S. Levy The effect of high doses of calcium-channel blockers on survival in primary pulmonary hypertension N Engl J Med 327 1992 76 81
3. M.J. Ricciardi, B.P. Knight, F.J. Martinez, M. Rubenfire Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine J Am Coll Cardiol 32 1998 1068 1073
4. O. Sitbon, M. Humbert, X. Jaïs, V. Ioos, A.M. Hamid, S. Provencher, G. Garcia, F. Parent, P. Hervé, G. Simonneau Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension Circulation 111 2005 3105 3111
5. R.J. Barst, L.J. Rubin, W.A. Long, M.D. McGoon, S. Rich, D.B. Badesch, B.M. Groves, V.F. Tapson, R.C. Bourge, B.H. Brundage, S.K. Koerner, D. Langleben, C.A. Kellar, S. Murali, B.F. Uretsky, L.M. Clayton, M.M. Jöbsis, S.D. Blackburn Jr, D. Shortino, J.W. Crow Primary Pulmonary Hypertension Study Group A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension N Engl J Med 334 1996 296 302
6. B.J. Schrader, S. Inbar, L. Kaufmann, R.E. Vestal, S. Rich Comparison of the effects of adenosine and nifedipine in pulmonary hypertension J Am Coll Cardiol 19 1992 1060 1064
7. O. Sitbon, M. Humbert, J.L. Jagot, O. Taravella, M. Fartoukh, F. Parent, P. Herve, G. Simonneau Inhaled nitric oxide as a screening agent for safely identifying responders to oral calcium-channel blockers in primary pulmonary hypertension Eur Respir J 12 1998 265 270
8. V.V. McLaughlin, S.L. Archer, D.B. Badesch, R.J. Barst, H.W. Farber, J.R. Lindner, M.A. Mathier, M.D. McGoon, M.H. Park, R.S. Rosenson, L.J. Rubin, V.F. Tapson, J. Varga, R.A. Harrington, J.L. Anderson, E.R. Bates, C.R. Bridges, M.J. Eisenberg, V.A. Ferrari, C.L. Grines, M.A. Hlatky, A.K. Jacobs, S. Kaul, R.C. Lichtenberg, J.R. Lindner, D.J. Moliterno, D. Mukherjee, G.M. Pohost, R.S. Rosenson, R.S. Schofield, S.J. Shubrooks, J.H. Stein, C.M. Tracy, H.H. Weitz, D.J. Wesley ACCF/AHA 2009 expert consensus document on pulmonary hypertension: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association Circulation 119 2009 2250 2294
9. N. Galiè, M.M. Hoeper, M. Humbert, A. Torbicki, J.L. Vachiery, J.A. Barbera, M. Beghetti, P. Corris, S. Gaine, J.S. Gibbs, M.A. Gomez-Sanchez, G. Jondeau, W. Klepetko, C. Opitz, A. Peacock, L. Rubin, M. Zellweger, G. Simonneau ESC Committee for Practice Guidelines (CPG) Guidelines for the diagnosis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT) Eur Heart J 30 2009 2493 2537
10. J.M. Morgan, D.G. McCormack, M.J. Griffiths, C.J. Morgan, P.J. Barnes, T.W. Evans Adenosine as a vasodilator in primary pulmonary hypertension Circulation 84 1991 1145 1149
11. M. Nootens, B. Schrader, E. Kaufmann, R. Vestal, W. Long, S. Rich Comparative acute effects of adenosine and prostacyclin in primary pulmonary hypertension Chest 107 1995 54 57
12. C.F. Opitz, L.J. Rubin Acute vasodilator testing in idiopathic pulmonary arterial hypertension: must we take NO for the answer? Eur Respir J 33 2009 1247 1249
13. Z.C. Jing, X. Jiang, Z.Y. Han, X.Q. Xu, Y. Wang, Y. Wu, H. Lv, C.R. Ma, Y.J. Yang, J.L. Pu Iloprost for pulmonary vasodilator testing in idiopathic pulmonary arterial hypertension Eur Respir J 33 2009 1354 1360
14. H. El-Kashef, M.M. Elmazar, O.A. Al-Shabanah, A.M. Al-Bekairi Effect of adenosine on pulmonary circulation of rabbits Gen Pharmacol 32 1999 307 313
15. A.Y. Saadjian, F. Paganelli, M.L. Gaubert, S. Levy, R.P. Guieu Adenosine plasma concentration in pulmonary hypertension Cardiovasc Res 43 1999 228 236
16. A.Y. Saadjian, F. Paganelli, M.A. Juin, C. Devaux, S. Lévy, R.P. Guieu Plasma beta-endorphin and adenosine concentration in pulmonary hypertension Am J Cardiol 85 2000 858 863
17. D. Montani, L. Savale, D. Natali, X. Jaïs, P. Herve, G. Garcia, M. Humbert, G. Simonneau, O. Sitbon Long-term response to calcium-channel blockers in non-idiopathic pulmonary arterial hypertension Eur Heart J 31 2010 1898 1907
18. A.R. Tonelli, H. Alnuaimat, K. Mubarak Pulmonary vasodilator testing and use of calcium channel blockers in pulmonary arterial hypertension Respir Med 104 2010 481 496
19. G.A. Haywood, J.F. Sneddon, Y. Bashir, S.H. Jennison, H.H. Gray, W.J. McKenna Adenosine infusion for the reversal of pulmonary vasoconstriction in biventricular failure A good test but a poor therapy Circulation 86 1992 896 902
20. E.C. Oliveira, A.L. Ribeiro, C.F. Amaral Adenosine for vasoreactivity testing in pulmonary hypertension: a head-to-head comparison with inhaled nitric oxide Respir Med 104 2010 606 611